ENSG: Parkinson Mark Vincent sold $18K of stock
By AlphaYouPublished Form 4
Parkinson Mark Vincent
Reporting filer
Parkinson Mark Vincent reported selling 100 shares of Ensign Group, Inc for about $18K ($179.62 a share on average). Form 4 filed Oct 19, 2026 lists 2 entries.
See the price move since this trade →
- Disclosed
- Oct 19, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Parkinson Mark Vincent | 2026-10-15 | A | Grant or award | 600 | 0 | 4,500 | 4 days | Filed terms
|
| Common Stock | Parkinson Mark Vincent | 2026-10-16 | S | Sale | 100 | 179.62 | 4,400 | 3 days | Filed terms
|
Common Stock
- Owner
- Parkinson Mark Vincent
- Date
- 2026-10-15
- Code
- A
- Action
- Grant or award
- Quantity
- 600
- Price
- 0
- Following holdings
- 4,500
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-15
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 600
- id: F1
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 4500
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Parkinson Mark Vincent
- Date
- 2026-10-16
- Code
- S
- Action
- Sale
- Quantity
- 100
- Price
- 179.62
- Following holdings
- 4,400
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-16
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F2
- transaction Shares: 100
- transaction Price Per Share: 179.62
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 4400
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Parkinson Mark Vincent: Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: These shares vest in three equal annual installments beginning October 15, 2027.
- F2: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2025.
Original sources
Prepared automatically from public filing data. Report a correction.